Does PALIVIZUMAB Cause Hypersensitivity? 61 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 61 reports of Hypersensitivity have been filed in association with PALIVIZUMAB (Synagis). This represents 0.5% of all adverse event reports for PALIVIZUMAB.
61
Reports of Hypersensitivity with PALIVIZUMAB
0.5%
of all PALIVIZUMAB reports
0
Deaths
12
Hospitalizations
How Dangerous Is Hypersensitivity From PALIVIZUMAB?
Of the 61 reports, 12 (19.7%) required hospitalization, and 3 (4.9%) were considered life-threatening.
Is Hypersensitivity Listed in the Official Label?
Yes, Hypersensitivity is listed as a known adverse reaction in the official FDA drug label for PALIVIZUMAB.
What Other Side Effects Does PALIVIZUMAB Cause?
Respiratory syncytial virus infection (1,692)
Pyrexia (1,055)
Death (856)
Bronchiolitis (724)
Cough (665)
Pneumonia (657)
Dyspnoea (466)
Nasopharyngitis (462)
Vomiting (445)
Influenza (398)
What Other Drugs Cause Hypersensitivity?
ETANERCEPT (10,846)
ADALIMUMAB (10,641)
METHOTREXATE (9,799)
TOCILIZUMAB (9,076)
ABATACEPT (8,945)
INFLIXIMAB (8,519)
RITUXIMAB (8,408)
ADAPALENE (8,356)
LEFLUNOMIDE (7,926)
CERTOLIZUMAB PEGOL (7,353)
Which PALIVIZUMAB Alternatives Have Lower Hypersensitivity Risk?
PALIVIZUMAB vs PALONOSETRON
PALIVIZUMAB vs PAMIDRONATE
PALIVIZUMAB vs PAMIDRONIC ACID
PALIVIZUMAB vs PANCRELIPASE
PALIVIZUMAB vs PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE